Results

Most recent

AMD-Neovascular

1–3 of 3 results for Marco A. Zarbin

An Assessment of the Impact of Disease Activity Criteria on Dosing Interval Assignment in Clinical Trial Patients With nAMD
Marco A. Zarbin, MD, PhD
Annual Meeting Talks
2023
Anti-VEGF Resistant Subretinal Fluid Associated With Reduced Risk of Macular Atrophy and Better Vision: Drug-Induced Choroidal New Vessel Homeostasis?
Marco A. Zarbin, MD, PhD
Annual Meeting Talks
2020
Rho Kinase Inhibition Reduces Photoreceptor Damage After Retinal Detachment: Possible Implications for Gene and Cell Therapy
Marco A. Zarbin, MD, PhD
Updates from the Field
2021